Offer - Urjas Oil for just ₹ 1 X
Myelosafe is a prescription drug, available for use as Capsule. Multiple Myeloma are some of its major therapeutic uses. Myelosafe also has some secondary and off-label uses. These are listed below.
The optimal dosage of Myelosafe is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Myelosafe are Weakness, Sleepiness, Edema. While these are the most often observed Myelosafe side effects, there are can be others also. These have been listed below. Normally, these side effects of Myelosafe are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Myelosafe has a Severe effect for pregnant women and Severe effect on lactating mothers. It is important to know if Myelosafe has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Myelosafe related warnings section.
Myelosafe can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Myelosafe in conditions like Neutropenia. The section on Myelosafe contraindications lists all such conditions.
Additionally, Myelosafe may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Myelosafe is not safe while driving, and is is not addictive in nature.
Myelosafe is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Myelosafe safe for pregnant women?
Myelosafe should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Myelosafe safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Myelosafe. So it is adviced to consult the doctor before using it.
What is the effect of Myelosafe on the Kidneys?
Myelosafe may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Myelosafe on the Liver?
There may be an adverse effect on the liver after taking Myelosafe. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Myelosafe on the Heart?
Myelosafe can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Myelosafe should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Myelosafe unless your doctor advises you to do so -
Is this Myelosafe habit forming or addictive?
Forming a habit of Myelosafe has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Myelosafe you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Myelosafe is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Myelosafe in mental disorders is not effective.
Interaction between Food and Myelosafe
Taking Myelosafe with food does not harm your health.
Interaction between Alcohol and Myelosafe
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Myelosafe.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 753-755
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Revlimid (lenalidomide)